Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

510(k) clearance for SenoRx's breast biopsy ultrasound system:

This article was originally published in Clinica

Executive Summary

SenoRx has received 510(k) clearance from the US FDA for its SenoSonix system, an adjunct to its EnCor breast biopsy device. The SenoSonix incorporates Aliso Viejo, California-based SenoRx's proprietary EnCor vacuum-assisted biopsy technologies with an ultrasound system developed by Ultrasonix Medical Corporation of Richmond, Canada. The product is scheduled to be launched in the US in January 2008, and SenoRx expects to receive the right to CE mark the device in the EU "in the near-term."

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT050022

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel